2018 American Transplant Congress

June 2-6, 2018 in Seattle, WA

View by Title View Sessions

View by Date

Jump to: View All • a b c d e f g h i j k l m n [o] p q r s t u v w x y z

Obese Patients Show Resistance to Narcotics Reduction after TPIAT for Chronic Pancreatitis

G. Yoshimatsu,¹ B. Naziruddin,³ K. Kumano,² H. Fernandez,³ E. Beecherl,³ N. Onaca.³
Obesity is Associated with Increased Risk of Mortality among Living Kidney Donors

R. Reed,¹ A. Massie,² D. Sawinski,³ P. MacLennan,¹ B. Shelton,¹ M. Mustian,¹ D. McWilliams,¹ V. Kumar,¹ R. Mannon,¹ R. Gaston,¹ D. Segev,² C. Lewis,¹ J. Locke.¹
Obesity is Not Associated with Worse Outcomes for Type 2 Diabetic Simultaneous Pancreas-Kidney (SPK) Transplant Recipients

R. Forbes, S. Niederhaus, A. Fox, J. Fridell, P. Abrams, O. Olaitan, F. Kandeel, R. Urban, M. Curry, J. Odorico.
Objective Markers of Frailty Predict Successful Listing and Survival for Renal Transplant

A. Tevar, K. Lemon, C. Wu, N. Shah, R. Mehta, C. Puttarajappa, P. Sood, S. Hariharan, A. Ganoza, M. Wijkstrom, M. Molinari, A. Humar, Y. Wang, J. Steel.
Objective Measures of Nutrition in Pre-Pancreas Transplant Patients with Type I Diabetes

S. Nagaraju, R. Mangus, T. Salisbury, W. Bush, J. Davis, J. Powelson, J. Fridell.
Occupational and Financial Outcomes of Directed and Non-Directed Living Liver Donors

J. Steel, M. Dulovich, K. Kingsley, S. Ganesh, O. Ola, A. Lai, S. Shen, N. Zharichenko, S. Nawaz, A. Tevar, C. Hughes, A. Humar.
Offer Acceptance Practices and Geographic Variability in Allocation MELD at Transplant

A. Wey,¹ S. Gentry,² J. Pyke,¹ D. Schladt,¹ T. Weaver,¹ N. Salkowski,¹ B. Kasiske,¹ A. Israni,¹ J. Snyder.¹
Offspring Living Kidney Donors Should Not Be Ruled Out

X. Luo, A. Massie, C. Holscher, D. Segev.
Once Daily CNI Administration Based on Pharmacodynamic Analysis for Preventing Viral Infection

Y. Matsuoka,¹ K. Iwasaki,² Y. Miwa,² K. Horimi,¹ K. Uchida,² T. Kobayashi.¹
Once-Daily MeltDose Tacrolimus Formulation and Renal Function in Caucasian Fast Tacrolimus Metabolizers: Does Early Identification Have an Impact in PK Sensitive Patients?

K. Budde,⁶ B. Suwelack,¹ D. Stevens,³ W. Du,⁴ C. Procaccianti,⁵ C. Maas,⁵ S. Bunnapradist.²
Once-Daily Prolonged-Release Tacrolimus versus Twice-Daily Tacrolimus in Liver Transplantation: A Meta-Analysis

R. Deng, B. Huang, Y. Shi, Y. Ma.
Once-Daily versus Twice-Daily Tacrolimus in De Novo Living Kidney Transplantation Patients: A Multicenter, Parallel Group, Open-Label, 5-Year Randomized Noninferiority Trial

Y. Kakuta,¹ M. Okumi,¹ K. Unagami,² M. Furusawa,¹ H. Ishida,¹ K. Tanabe.¹
One-Pump versus Two-Pump Normothermic Ex Vivo Perfusion Machines in Discarded Human Livers

A. Hassan, Q. Liu, D. Pezzati, A. Nassar, B. Soliman, M. Blum, P. Grady, G. Iuppa, T. Uso, J. Fung, K. Abu-Elmagd, C. Quintini.
One-Year Graft Survival for Longevity Matched Kidneys in the Post-KAS Era

A. Wilk,¹ M. Aeder,² V. Casingal,³ N. Turgeon.⁴
One-Year Outcomes in Patients with Advanced Liver Fibrosis or Compensated Cirrhosis from Chronic Hepatitis C Receiving Kidney Transplant Alone

P. Brown, F. Kumssa, D. Venkat.
Opiate Use Trends after Liver Transplantation and the Factors Associated with Post-Transplant Opiate Dependence

M. Siddiqui,¹ R. Kaur,¹ S. Dhoop,² N. Sulejmani,¹ R. Salgia.¹
Opioid Use Following Ultrasound-Guided Transverse Abdominis Plane Blocks in Living Donor Nephrectomy Patients

E. Henricksen,¹ D. Quan,¹ C. Freise.²
Opportunistic Infections after Kidney Transplantation Are Independent Risk Factor of Kidney Allograft Loss: A Retrospective Cohort Study

P. Attias,¹ G. Melica,² E. Audureau,³ D. Boutboul,⁵ N. De Castro,⁴ S. Gallien,² P. Grimbert,¹ M. Matignon.¹
Optimal Anti-Thymocyte Globulin Dose for Induction Immunosuppression in Kidney Transplantation

A. Mitrokhin, J. Goldman, B. Trivedi, V. Vidyasagar, N. Vadivel, M. Hart.
Optimal Protocol for ABO Incompatible Kidney Transplantations: Analysis of 400 Cases in a Single Center Experience

H. Kwon, Y. Kim, J. Choi, S. Shin, J. Jung, M. Cho, J. Kim, D. Han.
Optimizing Outcomes with a Collaborative Approach after Kidney Transplant in Hepatitis C-Positive Recipients Receiving Hepatitis C-Positive Grafts

A. Ray, R. Rubin, T. Ommert, R. Cross, C. Klein.
Opting out and Offers of 'Alibis' for Potential Living Kidney Donors in the US

R. Iskander,¹ S. Kulkarni,² C. Thiessen.²
OPTN VCA Waiting List Trends

J. Wainright, C. Wholley, W. Cherikh, J. Musick, D. Klassen.
Oral Health Related Quality of Life for Children with Kidney Disease

P. Verghese,¹ J. Sotillo,² J. Diaz,¹ E. Sarwas.²
Oral Vancomycin Monotherapy versus Combination Therapy in Solid Organ Transplant Recipients with Uncomplicated Clostridium difficile Infection: A Retrospective Cohort Study

G. Korayem,^1,2,4 K. Eljaaly,^2,3 K. Matthias,^2,4 T. Zangeneh.^4,5
Organ Donation and Transplantation in US States and Europe – Is There a Benefit to Opting Out?

R. J. Vela,¹ J. Pruszynski,¹ T. Mone,³ P. Niles,² M. Peltz.¹
Organ Procurement Organization Run Department of Motor Vehicle Office Leads to Increased Organ Donor Registry Enrollments

L. Dageforde,¹ W. Muren,² S-.H. Chang,¹ N. Vachharajani,¹ D. Brockmeier,² B. Anderson,¹ A. Khan,¹ J. Wellen,¹ S. Shenoy,¹ Y. Lin,¹ W. Chapman,¹ M. Doyle.¹
Organ Transplant Abuse in China (1): Scale

G. Yin,¹ D. Li,¹ M. Li,¹ M. Fu.²
Organ Transplant Abuse in China (2): Continued Growth after Gaining International Attention

G. Yin,¹ D. Li,¹ M. Li,¹ M. Fu.²
Organ Transplant Abuse in China (3): Transplants Conducted on Demand

G. Yin,¹ D. Li,¹ M. Fu,² Y. Xia.³
Organ Transplant Abuse in China (4): Organ Sources

D. Li, G. Yin.
Organ Transplant Abuse in China (5): Role of the Chinese State

D. Li,¹ Y. Xia,² M. Li,¹ G. Yin.¹
Organ Transplantation Associated with High Incidence of Anal Cancer and Pre-Cancer Lesions among HIV-Infected Women and Men

P. Chin-Hong,¹ B. Barin,² M. Berry,¹ M. DaCosta,¹ T. Darragh,¹ L. Rosenthal,³ S. Bartlett,⁴ D. Dieterich,⁵ F. Poordad,⁶ N. Nissen,⁶ M. Wong,⁷ P. Stock,¹ J. Palefsky.¹
Organ-Specific Differences in a Thymoglobulin and Belatacept-Based Protocol for Tolerance Induction in Non-Human Primates

W. Sommer, J. O., K. Robinson, A. Dehnadi, M. Hanekamp, I. Rosales, K. Pruner, R. Smith, R. Colvin, T. Kawai, G. Benichou, J. Madsen, J. Allan.
Origin and Pattern of Human Polyomaviruses Replication after Kidney Transplantation: A Prospective Study

E. Favi,¹ S. Delbue,² C. Colico,¹ P. Ferrante,² S. Villani,² I. Perna,² N. Mondoni,² A. Giussani,¹ L. Clementoni,¹ P. Messa,³ M. Ferraresso.¹
Origin and Traffic of Donor-Derived Extracellular Vesicles during Allo-Sensitization

F. Zeng,¹ W. Shufesky,¹ M. Yang,¹ Q. Liu,¹ A. Larregina,² A. Morelli.¹
Outcome Analysis of Renal Re-Transplantation Compared to a Matched Control Group of First Transplantation

A. Schwarz,¹ F. Schaefer,¹ T. Framke,² S. Linnenweber,¹ H. Haller.¹
Outcome Implications of Benzodiazepines and Opioid Co-Prescriptions before Kidney Transplantation

N. Lam,¹ M. Schnitzler,² D. Axelrod,³ V. Dharnidharka,⁴ D. Segev,⁵ A. Naik,⁶ H. Xiao,² R. Ouseph,² H. Randall,² G. Hess,⁷ B. Kasiske,⁸ D. Brennan,⁵ T. Alhamad,⁴ K. Lentine.²
Outcome of Second Kidney Transplantation According to Previous Pediatric Donor Type: A Retrospective Cohort Analysis

K. Phonphok, T. Duong, S. Panombualert, S. Bunnapradist.
Outcomes after Cardiac Transplantation for Adult Congenital Heart Disease in the Modern Era

X. Zeng,¹ R. Vela,² J. Pruszynski,² J. Martinez,² S. Ring,² M. Peltz.²
Outcomes after HIV+ Kidney Transplant: A HOPE in Action Study

C. Durand,¹ M. Bowring,¹ A. Tobian,¹ D. Brown,¹ N. Desai,¹ S. Bagnasco,¹ D. Ostrander,¹ A. Redd,¹ S. Huprikar,² B. Haydel,² S. Lerner,² S. Florman,² S. Chandran,³ A. Chao,³ J. Locke,⁴ S. Mehta,⁴ R. Freidman,⁵ N. Turgeon,⁵ A. Massie,¹ D. Segev.¹
Outcomes after HIV+ Liver Transplant: A HOPE in Action Study

C. Durand,¹ M. Bowring,¹ A. Tobian,^1,3 D. Brown,¹ A. Cameron,¹ S. Ottman,¹ K. Oshima,¹ D. Ostrander,¹ A. Redd,¹ S. Huprikar,² B. Haydel,² S. Lerner,² S. Florman,² S. Chandran,⁶ A. Chao,⁶ V. Kirchner,⁷ T. Pruett,⁷ A. Massie,¹ D. Segev.¹
Outcomes after Kidney Transplant (KTx) from Deceased Donors (DD) Aged ≥ 70

A. Srinivasan, R. Heilman, H. Khamash, K. Reddy, A. Moss.
Outcomes after Kidney Transplantation in Patients with AL Amyloid Following Autologous Stem Cell Transplantation

V. Gutgarts,^1,2 I. Jaffer Sathick,² C. Rosenbaum,³ T. Muthukumar,¹ H. Hassoun,⁴ C. Flombaum,² H. Landau.⁴
Outcomes Analysis of Liver Transplantation Combined with Neoadjuvant Therapy in Patients with Unresectable Locally-Advanced Cholangiocarcinoma

M. Wong,¹ J. Kim,¹ C. Eriksen,¹ T. Pearson,¹ J. Robbins,² B. George,³ M. Zimmerman,¹ J. Hong.¹
Outcomes and Risk Factors of Kidney Transplantation from Pediatric Donors to Adult Recipients

G. Chen, X. Liu, C. Wang, Z. Wu, C. Wang, L. Chen.
Outcomes Associated with Rabbit Anti-Thymocyte Globulin Induction According to Mg/Kg of Total Body Weight in Kidney Transplant Recipients

A. Brueckner, A. Logan, L. Bowman.
Outcomes from 194 Consecutive Split Left Liver Transplants: Comparison of Living versus Deceased Donors

D. Adamson, P. Tabrizian, M. Parides, K. Iyer, J. Moon, J. Chu, R. Arnon, S. Florman.
Outcomes from Brain Death Donors with Cardiac Arrest Accepted for Pancreas Transplantation

P. Ventura-Aguiar,¹ J. Ferrer,² D. Paredes,³ C. Rodriguez,³ C. Fontdevilla,² E. Esmatjes,⁴ J. Garcia-Valdecasas,² F. Oppenheimer,¹ F. Diekmann,¹ M. Ricart.¹
Outcomes in Liver and Combined Liver-Kidney Retransplantation

D. Sonnier, D. Bruce, H. Bohorquez, E. Bugeaud, I. Carmody, A. Cohen, A. Mathur, J. Seal, G. Loss.
Outcomes in Liver Transplant Patients on Renal Sparing Protocol

A. Polyak,¹ D. Ganger,² A. Shetty.²
Outcomes in Living Kidney Transplant Donor and Recipient Operations with Same vs. Different Surgeons

J. Sokolich,¹ J. Buggs,¹ D. Mahon,² E. Rogers,³ V. Bowers.¹
Outcomes in Renal Transplant Recipients with Bipolar Disorder: A Large Retrospective Cohort

S. Hamel,¹ D. Sawinski,² R. Weinrieb,³ S. Dave,³ J. Trofe-Clark.^1,2
Outcomes of ABO Non-Identical Pancreas Transplant

S. Nagaraju, R. Mangus, J. Fridell.
Outcomes of Antiviral Treatment (AVT) in Hepatitis C Virus (HCV) Liver Transplant (LT) Patients off Immunosuppression (IS) in Direct Acting Antivirals (DAA) Era

E. Agudelo,^1,2 I. Campos-Varela,³ N. Terrault.^1,2
Outcomes of C4d+ Immunostaining in Heart Transplantation: Is All Immunologic AMR Bad?

M. Rafiei, J. Patel, E. Kransdorf, R. Levine, S. Dimbil, S. Mersola, G. Esmailian, D. Geft, D. Chang, L. Czer, J. Kobashigawa.
Outcomes of DCD Renal Transplantation from Donors with Acute Kidney Injury

E. Grodstein, J. Yang, V. Nair, L. Teperman.
Outcomes of De Novo Donor Specific Antibodies in Pancreas Transplant Recipients

S. Parajuli, S. Alagusundaramoorthy, F. Aziz, N. Garg, R. Redfield, H. Sollinger, D. Kaufman, A. Djamali, J. Odorico, D. Mandelbrot.
Outcomes of Donation after Cardiac Death Liver Grafts from Donors ≥ 50 Years of Age: A Multi-Center Analysis

K. P. Croome,¹ A. K. Mathur,³ D. D. Lee,¹ A. A. Moss,³ C. B. Rosen,² J. K. Heimbach,² C. B. Taner.¹
Outcomes of Donor and Recipient Obesity in Kidney Transplantation

J. Buggs,¹ R. Mehta,² M. Adesunkanmi,² J. Boone,² E. Rogers,³ A. Kumar,⁴ V. Bowers.¹
Outcomes of Early Steroid Withdrawal in 6-Antigen Human Leukocyte Antigen (HLA)-Matched Kidney Transplant Recipients

H. Champion, K. Holdener, B. Astor, F. Aziz, D. Mandelbrot.
Outcomes of Enteric Conversion of Bladder Drained Pancreas; over a Decade of Experience at a Single Center

S. Riad,¹ D. Keys,¹ V. Vakil,¹ S. Jackson,² D. Berglund,² A. Matas,³ R. Kandaswamy.³
Outcomes of Hispanic Kidney Transplant Recipients under a Cyclosporine versus Tacrolimus Based Immunosuppression Protocol

P. West-Thielke, M. Campara, I. Tang, E. Benedetti.
Outcomes of Kidney Transplant Recipients with Early Allograft Inflammation: A Prospective Study

R. Mehta, S. Tandukar, P. Sood, C. Puttarajappa, C. Wu, N. Shah, A. Tevar, S. Hariharan.
Outcomes of Kidney Transplantation from HBsAg Positive Donors to HBsAb Positive Recipients

G. Chen, C. Wang, Z. Wu, X. Liu, C. Wang, L. Chen.
Outcomes of Liver Transplant in Sequential Eras in Patients with Polycystic Liver Disease at Various Stages of Disease

C. Desai,¹ J. Shurney,¹ P. Serrano Rodriguez,¹ A. Barritt,¹ D. Gerber,¹ A. Gruessner.²
Outcomes of Liver Transplantation for Hepatic Epithelioid Hemangioendothelioma in the U.S. (2002-2015)

T. Bittermann,¹ S. Prenner,¹ P. Abt,² D. Goldberg.^1,3
Outcomes of Livers Allocated to High UNOS Match Sequence Number Recipients at a High Volume Transplant Center

M. Park, L. De Gregorio, H. Bohorquez, D. Bruce, E. Bugeaud, I. Carmody, A. Cohen, A. Mathur, D. Sonnier, J. Seal, G. Loss.
Outcomes of Moderately Macrosteatotic Liver Allografts

J. Alvikas, A-.P. Deeb, K. Lemon, X. Chen, S. Malik, G. Zeng, C. Hughes, A. Humar, A. Tevar.
Outcomes of Organ Transplantation from Donors with Cancer History

Z. Guo,¹ X. He,¹ S. Huang.¹
Outcomes of Pediatric Donor Liver Grafts for Adult Transplantation: A National Analysis

J. Yerxa, Q. Gao, U. Scheuermann, R. Davis, D. Vikraman, A. Barbas.
Outcomes of Pregnancies in Female Liver Transplant Recipients

L. Coscia,¹ D. Armenti,¹ P. Patel,² S. Constantinescu,^1,3 M. Moritz.^1,2,4
Outcomes of Renal Transplantation in Pediatric Patients with VACTERL Association

J. Diaz,¹ B. Chavers,² S. Chinnakotla,³ P. Verghese.²
Outcomes of Renal Transplants from Donors with Positive Blood or Urine Cultures

L. Chen,¹ D. Kamiyama,² L. Francalacci,¹ E. Zhu,² M. Donnelley,² N. Clayton,² K. Alman,¹ A. De Mattos,¹ J. Brown.³
Outcomes of Retroperitoneoscopic Live Donor Nephrectomy (RPLDN): Experience of 1100 Cases at a Single Center

K. Omoto,^1,2 M. Okumi,¹ Y. Kakuta,¹ H. Noguchi,¹ K. Unagami,¹ M. Inui,¹ H. Ishida,¹ K. Tanabe.¹
Outcomes of Second Opinion Kidney Transplant Evaluations

M. Harhay, T. Bajakian, K. Ranganna, G. Malat, S. Guy, G. Xiao, L. Levin Mizrahi, D. Reich.
Outcomes of Subsequent Pregnancies in Female Heart Transplant Recipients

S. Rao,^1,2 D. Armenti,¹ L. Coscia,¹ S. Constantinescu,^1,2 M. Moritz.^1,3,4
Outcomes of Transplant Patients with Encapsulating Peritoneal Sclerosis(EPS) Treated with Tamoxifen and Steroids

R. Parthasarathy,¹ T. Fairhead,^1,2 B. McCormick,^1,2 G. Knoll,^1,2 S. Hoar.^1,2
Outcomes of Very Old Kidney Recipients of Grafts from Very Old Donors

H. Trujillo, A. García, T. Cavero, B. Redondo, C. Moliz, T. Bada, E. González, M. Praga, A. Andrés.
Outpatient Prophylactic Valganciclovir Dose Optimization Post-Renal Transplant

M. Spinner,¹ V. Athans,¹ C. Koval.²
Overcoming Barriers to Transplant: An A2 to B Program Need Not Be Difficult, Expensive, or Time Consuming Even for Large Centers

S. Radomski, B. Diedrich, D. Li, M. Awwad, S. Rosen-Bronson, A. Langeberg, A-.A. Hamby, M. Cooper, A. Gilbert.
Overexpression of BAX, NOL3, and XIAP Apoptotic Genes Participates in Calcineurin Inhibitors Nephrotoxicity: New Insights into Chronic Allograft Dysfunction

L. Garcia-Covarrubias,¹ G. Queipo,² M. Fonseca,² D. Alcantara,¹ P. Prieto,¹ H. Diliz,¹ A. Garcia,¹ H. Hinojosa,¹ A. Cicero,¹ G. Melendez,³ M. Alamilla,³ R. Lascurain,⁴ V. Soto.⁵
OX40 Costimulation Prevents Induction of Foxp3⁺ Tregs through Upregulation of Novel Repressors of Foxp3 Gene Expression

X. Zhang,¹ X. Xiao,¹ P. Lan,¹ J. Li,¹ Y. Dou,¹ W. Chen,¹ N. Ishii,² S. Chen,¹ E. Taparowsky,³ X. Li.^1,4

Jump to: View All • a b c d e f g h i j k l m n [o] p q r s t u v w x y z